12:09pm ET
Investing
Executive Pay Up 14% in 2011
The data is from a major union, and, therefore, may have a bias against chief executives. Numbers can be bent. The AFL-CIO reports that CEO pay rose 14% last year: According to…
Companies
/Healthcare
Bristol-Myers Squibb Company
$63.06
▲ $0.22 (+0.35%) today
Markets closed · 9:07am ET
BMY Coverage
Page 346:52am ET
Media
Media Digest (4/5/2012) Reuters, WSJ, NYT, FT, Bloomberg
After legal issues slowed their progress last year, foreclosures are about to increase. (Reuters) Time Warner Cable (NYSE: TWC) may end its deal with Current TV because of low ratings. (Reuters) The…
9:52am ET
Health and Healthcare
The Inevitable Amylin Buyout (AMLN, BMY, LLY, ALKS)
If there was a merger candidate which ever made sense in biotech and pharma it is Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN). News from Bloomberg is out that the company has rejected an offer to…
6:37am ET
Media
Media Digest (3/2/2012) Reuters, WSJ, FT, Bloomberg
Anheuser-Busch InBev NV may buy China’s Kingway Brewery Holdings’ assets. (Reuters) The Department of Justice is expected to widen its probe of mortgage-backed securities. (Reuters) AT&T (NYSE: T) sets new standards that will impose penalties…
10:33am ET
Investing
Gilead Defended By Analyst As Competitors Gain Momentum (GILD, BMY, VRTX, ACHN)
Gilead Sciences, Inc. (NASDAQ: GILD) has recovered from its pre-market lows on the devastating news that its Hepatitis C drug experienced close to a total failure in an arm of a late-stage…
4:17pm ET
Investing
Drug & Biotech Makers Respond Unfavorably To Obama Budget Proposals (AMGN, BIIB, BMY, GSK, JNJ, MRK, PFE)
The Pharmaceutical Research and Manufacturers of America (PhRMA) has spoken out against the new 2013 budget proposed by President Obama. PhRMA represents leading pharmaceutical research and biotechnology companies and some of the…
4:08pm ET
Investing
24/7 Wall St. Closing Bell (GD, VALE, GMCR, GLW, CHK, ARG, ACAT, T, BMY, CAT, CY, LMT, MKC, MWW, POT, RTN, VIST, RNWK, MNTA, NFLX, EFSC)
All three major US indexes opened higher this morning, but enthusiasm tapered off quickly and steadily, if not sharply. A drop in the number of new home sales and a smaller-than-expected rise…
7:51am ET
Investing
Merger-Arbs Cleaning Up in Inhibitex Buyout (INHX, BMY)
It is not that often that investors get to clean up in a merger arbitrage spread any longer. The buyout of Inhibitex, Inc. (NASDAQ: INHX) by Bristol-Myers Squibb Company (NYSE: BMY) appears…
Jon C. Ogg 1:37pm ET
Health and Healthcare
Pharma Value Beyond The Patent Expiration Cliff (PFE, MRK, BMY, TEVA, AMGN, GSK)
The tide of patent expirations that is washing over big pharmaceutical houses is cresting now and investors have begun looking forward to how these companies will deal with some sharp blows to…
3:47pm ET
Investing
Achillion Pharma, Too Much of a Good Thing After 50% Gain? (ACHN, MRK, GILD, VRUS, BMY, INHX, VRTX)
Achillion Pharmaceuticals, Inc. (NASDAQ: ACHN) has been on fire due to the rapid interest of hepatitis C treatments and the bidding of players in the sector. With Merck & Co. (NYSE: MRK) driving further…
11:11am ET
Investing
Hepatitis-C to the Moon (BMY, INHX, ACHN, IDIX, VRTX)
You know how stocks sometimes react to news on peers… Today we are again seeing a run in the world of Hepatitis C drug candidates after news that Bristol-Myers Squibb Co. (NYSE: BMY)…
8:06am ET
Investing
Inhibitex Stock up 150% in Pre-Market (BMY, INHX)
Bristol-Myers Squibb (NYSE: BMY) will pay $2.5 billion in cash (a 163% premium to Friday’s closing price) for hepatitis C drug developer Inhitibex Inc. (NASDAQ: INHX).
Paul Ausick 6:47am ET
Investing
What’s Important in the Financial World (1/9/2012) Chevy Volt Revivial, M&A Monday
Deal makers were busy over the weekend. Strategic considerations were more the driver of activity than an improved economy, however. Lions Gate Entertainment (NYSE: LGF) will buy Summit Entertainment for $400 million,…
6:46am ET
Media
Media Digest (1/9/2012) Reuters, WSJ, NYT, FT, Bloomberg
http://platform.twitter.com/widgets/hub.1324331373.html The U.S. may start legal proceedings against Swiss financial firm Wegelin & Co. based on beliefs that it helped shield Americans from taxes. (Reuters) The EPA may send fresh water to…
5:07pm ET
Investing
Bristol-Myers Squibb (BMY) To Buy Inhibitex (IHNX)
Bristol-Myers (NYSE: BMY) will buy Inhibitex (NASDAQ: IHNX) for $26 a share about 2.5x what the smaller company’s shares traded for on Friday. The entire consideration, all in case, for Inhibitex, is…
Douglas A. McIntyre